Archemix IPO aims to raise $64 million

10/24/2007 | MSN Money

Cambridge, Mass.-based Archemix Corp. says it plans to issue 4.5 million shares of stock in its IPO, which is intended to raise about $64 million. The funds will be used for R&D for new preclinical and clinical drug candidates including aptamer products for cardiovascular disease, blood disorders and cancer.

View Full Article in:

MSN Money

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Regulatory Analyst
Delta Dental
Alpharetta, GA
Program Coordinator/Lecturer for the Regulatory Science program
Johns Hopkins University
Washington, DC
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA